The reputation of Aier Eye Hospital, one of China’s most prominent private healthcare giants, is under significant strain following allegations of sexual harassment involving a high-ranking executive. In mid-March, a sales manager for a pharmaceutical firm, identified by the pseudonym Lin Ran, reported that she was physically harassed by Pan, the director of the Hangzhou branch, during a corporate charity event. According to the victim's account, Pan lured her into his office under the guise of offering a gift before escalating to physical contact and verbal propositions.
Beyond the immediate assault, the case highlights the pervasive issue of professional retaliation within the Chinese corporate and medical sectors. Lin Ran alleges that following her refusal, Pan attempted to leverage his professional network to silence her, contacting her superiors and even those of her husband. This use of industrial influence to exert pressure on victims underscores the deep-seated power imbalances that often characterize the relationships between high-status medical professionals and pharmaceutical representatives in China.
In response to the mounting public pressure and media coverage, Aier Eye Hospital’s headquarters announced that Pan has been suspended pending the results of a police investigation. While the local public security bureau has officially filed an administrative case, the situation remains legally complex. Authorities have noted that current evidence supports a charge of administrative 'indecency'—a public security violation—but does not yet meet the rigorous evidentiary threshold required for a criminal charge of 'forcible indecency.'
This incident adds to a growing list of controversies for Aier Eye Hospital, a listed company that has previously faced scrutiny over patient safety and aggressive sales tactics. For many observers, the case is a litmus test for how China’s private healthcare sector handles internal ethics and workplace safety. The victim has stated that she is not seeking financial compensation but is instead pursuing a formal apology and legal accountability, a stance that has resonated widely on Chinese social media platforms.